financetom
Business
financetom
/
Business
/
S&P Global Set for Better Q2 on Strong June Issuance, Morgan Stanley Says
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
S&P Global Set for Better Q2 on Strong June Issuance, Morgan Stanley Says
Jul 7, 2025 8:12 AM

10:58 AM EDT, 07/07/2025 (MT Newswires) -- S&P Global ( SPGI ) is on track to post better-than-expected Q2 results after a rebound in June credit issuance supported confidence in full-year guidance, Morgan Stanley said in a note Monday.

The firm said total Q2 issuance declined 7% from a year earlier, but June issuance rose 13%, helping offset weaker volumes in April and May.

Morgan Stanley now expects S&P Global's ( SPGI ) Q2 ratings revenue to fall 2% year over year, a smaller decline than the previously estimated 5%.

"We think the quarter will shape up to be better-than-feared, given investor caution following soft credit markets in April and May," according to the note.

The firm raised its Q2 EPS estimate for S&P Global ( SPGI ) by 2% and said the company is likely to maintain its full-year outlook, supported by improved issuance trends in the second half.

Morgan Stanley increased its price target on S&P Global ( SPGI ) to $595 from $587 and reiterated an overweight rating.

Price: 530.90, Change: +1.28, Percent Change: +0.24

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Immix Biopharma Says NXC-201 Safety Profile Shows Absence of Neurotoxicity in Low-Volume Disease
Immix Biopharma Says NXC-201 Safety Profile Shows Absence of Neurotoxicity in Low-Volume Disease
Jul 11, 2025
10:21 AM EDT, 07/11/2025 (MT Newswires) -- Immix Biopharma ( IMMX ) said Friday the safety profile for its investigational CAR-T cell therapy NXC-201 includes an absence of neurotoxicity of any grade in low-volume disease. The company said this safety profile supports potential future indication expansion. Immix Biopharma ( IMMX ) also said it remains on track to submit a...
Google agrees $36 million fine for anti-competitive deals with Australia telcos
Google agrees $36 million fine for anti-competitive deals with Australia telcos
Aug 17, 2025
SYDNEY, Aug 18 (Reuters) - Google agreed on Monday to pay a A$55 million ($35.8 million) fine in Australia after the consumer watchdog found it had hurt competition by paying the country's two largest telcos to pre-install its search application on Android phones, excluding rival search engines. The fine extends a bumpy period for the Alphabet-owned internet giant in Australia,...
Update: Market Chatter: Meta Platforms Unlikely to Propose More Changes to Pay-or-Consent Model Despite EU Fine Risk
Update: Market Chatter: Meta Platforms Unlikely to Propose More Changes to Pay-or-Consent Model Despite EU Fine Risk
Jul 11, 2025
10:22 AM EDT, 07/11/2025 (MT Newswires) -- (Updates with company response in the fourth paragraph.) Meta Platforms ( META ) is almost certain to be hit by new antitrust charges in the EU as the Facebook owner is very unlikely to tweak its pay-or-consent model, Reuters reported Friday, citing people with direct knowledge of the matter. The social media company...
Update: Polestar Facing NHTSA Recall Query Over Continued Rear-View Camera Outages
Update: Polestar Facing NHTSA Recall Query Over Continued Rear-View Camera Outages
Jul 11, 2025
10:18 AM EDT, 07/11/2025 (MT Newswires) -- (Updates with the NHTSA's confirmation throughout and the latest stock movement in the sixth paragraph.) Polestar Automotive (PSNY) is facing a US National Highway Traffic Safety Administration recall query covering 27,816 certain 2021 to 2025 Polestar 2 vehicles due to continued loss of rear-view camera display, the regulator said in a notice on...
Copyright 2023-2026 - www.financetom.com All Rights Reserved